GLYC Old Correlations

GLYCDelisted Stock  USD 0.16  0.01  5.88%   
The current 90-days correlation between GLYC Old and Applied Therapeutics is 0.03 (i.e., Significant diversification). The correlation of GLYC Old is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

GLYC Old Correlation With Market

Significant diversification

The correlation between GLYC Old and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding GLYC Old and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Moving against GLYC Stock

  0.36PPERF Bank Mandiri PerseroPairCorr
  0.49PG Procter GamblePairCorr
  0.39VZ Verizon Communications Earnings Call TomorrowPairCorr
  0.33TRV The Travelers CompaniesPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SLNCTMX
GLMDCDTX
SLNCDTX
SLNGLMD
MGNXAPLT
CTMXCDTX
  
High negative correlations   
MGNXCDTX
GLMDAPLT
SLNMGNX
MGNXGLMD
SLNAPLT
MGNXCTMX

Risk-Adjusted Indicators

There is a big difference between GLYC Stock performing well and GLYC Old Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GLYC Old's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Delisting Warning - GLYC

GLYC Old was delisted

The entity GLYC Old with a symbol GLYC was delisted from NASDAQ Exchange. Please try Crescent Biopharma, with a symbol CBIO from now on. Check all delisted instruments accross multiple markets.

GLYC Old Corporate Executives

Elected by the shareholders, the GLYC Old's board of directors comprises two types of representatives: GLYC Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GLYC. The board's role is to monitor GLYC Old's management team and ensure that shareholders' interests are well served. GLYC Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GLYC Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
Brian HahnCFO and Principal Accounting OfficerProfile

Still Interested in GLYC Old?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.